Ohne eingeschaltetes JavaScript können Sie PSIAC nicht in vollem Umfang nutzen.
Literaturverzeichnis
White SI. Br J Dermatol. Jan 1996; 134(1): 188-9
Pubmed [776]
White WB. Arch Intern Med. Sep 1986; 146(9): 1833-4
Pubmed [637]
White. Lancet (1965) ii, 441 [554]
Whittington HG. Am J Psychiatry. Jun 1969; 125(12): 1725-9
Pubmed [1301]
WHO. International travel and health: vaccination, requirements and health advise. Geneva : WHO 2001 [1440]
WHO. International travel and health: vaccination, requirements and health advise. Geneva: WHO 2001 [905]
Wiciński M. Curr Opin Hematol. Jan 2018; 25(1): 22-28
Pubmed [8037]
Wiciński M. J Psychiatr Pract. Mar 2017; 23(2): 114-120
Pubmed [10155]
Wictorin K. Acta Neurol Scand. May 2016; 133(5): 355-60
Pubmed [9923]
Wiegman DJ. AIDS. Jun 2009; 23(9): 1184-5
Pubmed [3090]
Wiemer-Kruel A. Neuropediatrics. Dec 2019; 50(6): 400-403
Pubmed [9831]
Wierzbicki AS. QJM. Oct 1997; 90(10): 631-4
Pubmed [3959]
Wiese Simonsen K. Forensic Sci Int. Jan 2013; 224(1-3): 44-50
Pubmed [9553]
Wiesinger H. Br J Clin Pharmacol. Dec 2015; 80(6): 1399-410
Pubmed , Volltext , DOI [4596]
Wiest D. Clin Pharmacokinet. Mar 1995; 28(3): 190-202
Pubmed [10467]
Wiest DB. Clin Pharmacokinet. Jun 2012; 51(6): 347-56
Pubmed [10466]
Wietholtz H. Eur J Clin Pharmacol. Jan 1989; 36(4): 401-6
Pubmed [727]
Wigen CL. Clin Infect Dis. Jun 2002; 34(12): 1651-2
Pubmed [2025]
Wightman RS. Ann Pharmacother. Apr 2011; 45(4): 547
Pubmed [9439]
Wightman RS. Clin Toxicol (Phila). Jun 2016; 54(5): 454-8
Pubmed [9575]
Wijnands WJ. Drug Metab Dispos. Nov 1990; 18(6): 954-7
Pubmed [8233]
Wilbur K. Clin Pharmacokinet. Apr 2000; 38(4): 355-65
Pubmed [9309]
Wilby KJ. Ann Hepatol. Mar 2012; 11(2): 179-85
Pubmed [6325]
Wilby KJ. Eur J Drug Metab Pharmacokinet. Dec 2018; 43(6): 637-644
Pubmed [6920]
Wilcock GK. Lancet. Apr 1987; 1(8538): 929-30
Pubmed [2387]
Wilcox JB. N Z Med J. Sep 1981; 94(692): 235-6
Pubmed [5308]
Wilde MI. Drugs. Mar 1995; 49(3): 411-39
Pubmed [10878]
Wilder BJ. Neurology. Sep 1978; 28(9 Pt 1): 892-6
Pubmed [2458]
Wilfong AA. Neuropsychiatr Dis Treat. Sep 2006; 2(3): 269-80
Pubmed , Volltext , DOI [9423]
Wilkins E. J HIV Ther. Nov 2004; 9(4): 87-91
Pubmed [7115]
Willcox Wh. The nature, revention and treatment of hear pyrexia: The clinical aspect. BMJ (81920) 1, 392-7 [2058]
Williams B. Eur Heart J. Sep 2018; 39(33): 3021-3104
Pubmed [8353]
Williams B. J Hypertens. Oct 2018; 36(10): 1953-2041
Pubmed [8483]
Williams CS. Ann Pharmacother. Feb 2000; 34(2): 255-7
Pubmed [5564]
Williams D. Clin Pharmacokinet. Jan 2002; 41(5): 343-70
Pubmed [4728]
Williams ET. Drug Metab Lett. Dec 2011; 5(4): 280-9
Pubmed [9247]
Williams FM. Clin Pharmacokinet. Sep 1985; 10(5): 392-403
Pubmed [8367]
Williams JA. Drug Metab Dispos. Nov 2002; 30(11): 1266-73
Pubmed [4671]
Williams JM. Cancer Epidemiol Biomarkers Prev. Oct 2010; 19(10): 2582-9
Pubmed , Volltext , DOI [375]
Williams SA. J Clin Psychiatry. Jan 1996; 57 Suppl 1: 7-11
Pubmed [2290]
Williams SE. Tubercle. Mar 1985; 66(1): 49-54
Pubmed [6863]
Williamson B. Antimicrob Agents Chemother. Dec 2013; 57(12): 6366-9
Pubmed , Volltext , DOI [430]
Williamson HE. Res Commun Chem Pathol Pharmacol. Jul 1988; 61(1): 141-4
Pubmed [13051]
Williamson KM. Clin Pharmacol Ther. Mar 1998; 63(3): 316-23
Pubmed [6097]
Willmore LJ. Epilepsia. Feb 2009; 50(2): 163-73
Pubmed [2077]
Willoughby SR. J Am Coll Cardiol. Sep 2012; 60(10): 887-94
Pubmed [12053]
Wilmink T. Drug Saf. Jun 1996; 14(6): 406-23
Pubmed [5025]
Wilner et al. (1996) Eur Neuropsychopharmacol 6 (Suppl 3), 38 [2498]
Wilner et al. Biol Psychiatry (1991) 29, 354S [2298]
Wilner KD, DeMattos SB, Anziano RJ, Apseloff G, Gerber N. Lack of CYP 2D6 inhibition by ziprasidone in healthy volunteers. Biol Psychiary (1997) 42, 42S [2495]
Wilner KD, Hansen RA, Folger CJ, Geoffroy P. The pharmacokinetics of ziprasidone in healthy volunteers treated with cimetidine or antacid. Br J Clin Pharmacol (2000) 49 (Suppl1), 57S-60S [2493]
Wilner KD. Br J Clin Pharmacol. Jan 2000; 49 Suppl 1(Suppl 1): 57S-60S
Pubmed [13027]
Wilson CB. J Pediatr. Jun 1985; 106(6): 1049-56
Pubmed [12343]
Wilson et al. N Engl J Med (1970) 282, 1063-1067 [1590]
Wind S. Clin Drug Investig. Mar 2014; 34(3): 173-82
Pubmed [7445]
Wind S. Clin Pharmacokinet. Sep 2019; 58(9): 1131-1147
Pubmed [13589]
Windorfer A Jr. Neuropadiatrie. Feb 1977; 8(1): 29-41
Pubmed [1048]
Wingård L. J Affect Disord. Aug 2017; 217: 16-23
Pubmed [4592]
Winsemius A. J Clin Pharmacol. Sep 2014; 54(9): 1038-47
Pubmed [3960]
Winter H. Antimicrob Agents Chemother. Feb 2015; 59(2): 1219-24
Pubmed , Volltext , DOI [5199]
Winter HR. Clin Pharmacol Ther. Dec 2004; 76(6): 579-87
Pubmed [5555]
Winter HR. Drug Metab Dispos. Aug 2000; 28(8): 865-8
Pubmed [4453]
Winter HR. Hum Psychopharmacol. Oct 2007; 22(7): 469-76
Pubmed [2826]
Winterfield JR. HeartRhythm Case Rep. Sep 2015; 2(4): 280-282
Pubmed , Volltext , DOI [8263]
Winton JC. Am J Med Sci. Feb 2013; 345(2): 160-2
Pubmed [3859]
Wire MB. Clin Pharmacokinet. Jan 2006; 45(2): 137-68
Pubmed [4805]
Wirtz PW. Clin Pharmacol Ther. Jul 2009; 86(1): 44-8
Pubmed [11394]
Wisialowski T. J Pharmacol Exp Ther. Jul 2006; 318(1): 352-9
Pubmed [8971]
Wit FW. AIDS. Dec 2001; 15(18): 2423-9
Pubmed [7093]
Witkin JM. Adv Pharmacol. Jan 2020; 89: 311-356
Pubmed [12078]
Witmer DR. Drug Intell Clin Pharm. Jun 1984; 18(6): 483-6
Pubmed [6794]
Witt et al. Ann Pharmacother (1993) 27, 1463-4 [786]
Wittmann et al. Neuro Endocrinol Lett. 2010 Apr 29;31(2):203-207 [2210]
WITTON K. Am J Psychiatry. Feb 1965; 121: 812-3
Pubmed [573]
Wodak J. Med J Aust. Dec 1972; 2(23): 1277-82
Pubmed [1265]
Woelk H. Alcohol Alcohol. Nov 1998; 33(6): 631-8
Pubmed [11041]
Woelk H. Phytomedicine. Feb 2010; 17(2): 94-9
Pubmed [3638]
Wójcikowski et al. Pharmacol Rep. 2009 Sep-Oct;61(5):851-8 [1822]
Wójcikowski J. Biochem Pharmacol. Jul 2008; 76(2): 258-67
Pubmed [11692]
Wójcikowski J. Biochem Pharmacol. Jul 2014; 90(2): 188-95
Pubmed [145]
Wójcikowski J. Biochem Pharmacol. Oct 2010; 80(8): 1252-9
Pubmed [90]
Wójcikowski J. Drug Metab Dispos. Mar 2006; 34(3): 471-6
Pubmed [214]
Wójcikowski J. Eur Neuropsychopharmacol. May 2004; 14(3): 199-208
Pubmed [177]
Wójcikowski J. Pharmacol Rep. Dec 2014; 66(6): 1122-6
Pubmed [1481]
Wójcikowski J. Pharmacol Rep. Sep 2009; 61(5): 851-8
Pubmed [422]
Wójcikowski J. Pol J Pharmacol. Jul 2002; 54(4): 407-10
Pubmed [1178]
Wójcikowski, Daniel. Pharmacol Rep. 2009 Sep-Oct;61(5):851-8 [2074]
Wojtczak A. Pharmacol Rep. Jun 2014; 66(3): 511-4
Pubmed [1441]
Wolf (2006) Drugs Res Dev 7:163-172 [2794]
Wolf E. Mov Disord. Jul 2010; 25(10): 1357-63
Pubmed [10097]
Wolfe EJ. Pharmacotherapy. May 1997; 17(3): 591-8
Pubmed [7291]
Wolfes J. Cardiovasc Toxicol. Dec 2020; 20(6): 531-538
Pubmed [9882]
Wolfgang Forth, Allgemeine und spezielle Pharmakologie und Toxikologie.Mar 2018: 579-580 [2611]
Wolfsperger M. Pharmacopsychiatry. Nov 2005; 38(6): 326-7
Pubmed [9504]
Bildrechte: © spinetta / Fotolia